Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats
暂无分享,去创建一个
[1] D. Grahame-Smith,et al. Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by l‐tryptophan or 5‐methoxy‐N,N‐dimethyltryptamine in rats treated with a monoamine oxidase inhibitor , 1971, British journal of pharmacology.
[2] E. Azmitia,et al. Selective destruction of the serotonergic fibers of the fornix-fimbria and cingulum bundle increases 5-HT1 but not 5-HT2 receptors in rat midbrain. , 1983, European journal of pharmacology.
[3] C. Dourish. A PHARMACOLOGICAL ANALYSIS OF THE HYPERACTIVITY SYNDROME INDUCED BY β‐PHENYLETHYLAMINE IN THE MOUSE , 1982, British journal of pharmacology.
[4] H. Praag. Depression, suicide and the metabolism of serotonin in the brain ☆ , 1982 .
[5] C. D. Andrews,et al. Differential involvement of dopamine-containing tracts in 5-hydroxytryptamine-dependent behaviours caused by amphetamine in large doses , 1982, Neuropharmacology.
[6] K. Fuxe,et al. Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons. , 1972, European journal of pharmacology.
[7] F. Hirata,et al. Mepacrine treatment prevents immobilization-induced desensitization of beta-adrenergic receptors in rat hypothalamus and brain stem , 1981, Brain Research.
[8] A. Lees,et al. BACKWARD WALKING AND CIRCLING: BEHAVIOURAL RESPONSES INDUCED BY DRUG TREATMENTS WHICH CAUSE SIMULTANEOUS RELEASE OF CATECHOLAMINES AND 5‐HYDROXYTRYPTAMINE , 1979, British journal of pharmacology.
[9] T. Harris,et al. Life events and psychiatric disorders Part 2: nature of causal link , 1973, Psychological Medicine.
[10] B. Jacobs,et al. Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine. , 1976, European journal of pharmacology.
[11] J. Leysen,et al. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. , 1982, Molecular pharmacology.
[12] E L Bliss,et al. Relationship of stress and activity to brain dopamine and homovanillic acid. , 1971, Life sciences. Pt. 1: Physiology and pharmacology.
[13] M. H. Joseph,et al. Stress-induced release of 5-HT in the hippocampus and its dependence on increased tryptophan availability: an in vivo electrochemical study , 1983, Brain Research.
[14] J. Hall,et al. A BEHAVIOURAL AND BIOCHEMICAL STUDY IN RATS OF 5‐HYDROXYTRYPTAMINE RECEPTOR AGONISTS AND ANTAGONISTS, WITH OBSERVATIONS ON STRUCTURE‐ACTIVITY REQUIREMENTS FOR THE AGONISTS , 1981, British journal of pharmacology.
[15] J. Weiss. Effects of coping responses on stress. , 1968, Journal of comparative and physiological psychology.
[16] G. Curzon,et al. Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour , 1983, Neuropharmacology.
[17] R. Kvetňanský,et al. CATECHOLAMINES AND CORTICOSTEROIDS IN ACUTE AND REPEATED STRESS , 1976 .
[18] R. Rose,et al. The relation of psychological stress to onset of medical illness. , 1976, Annual review of medicine.
[19] B. Carroll,et al. Acute and chronic stress effects on open field activity in the rat: Implications for a model of depression , 1981, Neuroscience & Biobehavioral Reviews.
[20] B. Jacobs,et al. An animal behavior model for studying central serotonergic synapses. , 1976, Life sciences.
[21] E. Bliss,et al. Response of neurogenic amines to aggregation and strangers. , 1969, The Journal of pharmacology and experimental therapeutics.
[22] M. Palkovits,et al. Effect of stress on serotonin concentration and tryptophan hydroxylase activity of brain nuclei. , 1976, Neuroendocrinology.
[23] D. Grahame-Smith. STUDIES IN VIVO ON THE RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5‐HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L‐TRYPTOPHAN , 1971, Journal of neurochemistry.
[24] M. Seligman,et al. Failure to escape traumatic shock. , 1967, Journal of experimental psychology.
[25] S H Snyder,et al. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.
[26] D. Cooke,et al. The Aetiological Importance of Stressful Life Events , 1983, British Journal of Psychiatry.
[27] J. Deakin,et al. THE EFFECTS OF PUTATIVE 5‐HYDROXYTRYPTAMINE ANTAGONISTS ON THE BEHAVIOUR PRODUCED BY ADMINISTRATION OF TRANYLCYPROMINE AND L‐TRYPTOPHAN OR TRANYLCYPROMINE AND L‐DOPA TO RATS , 1978, British journal of pharmacology.
[28] E. Stone. Reduction by stress of norepinephrine‐stimulated accumulation of cyclic AMP in rat cerebral cortex , 1979, Journal of neurochemistry.
[29] C. D. Andrews,et al. The effects of lesions produced by 5,7-dihydroxytryptamine on 5-hydroxytryptamine-mediated behaviour induced by amphetamine in large doses in the rat , 1984, Neuropharmacology.
[30] M. H. Joseph,et al. EFFECTS OF IMMOBILIZATION AND FOOD DEPRIVATION ON RAT BRAIN TRYPTOPHAN METABOLISM , 1972, Journal of neurochemistry.
[31] G. Curzon,et al. Effects of hydrocortisone and immobilization on tryptophan metabolism in brain and liver of rats of different ages. , 1975, Biochemical pharmacology.
[32] J. Weiss,et al. Behavioral depression produced by an uncontrollable stressor: Relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain , 1981, Brain Research Reviews.
[33] K. O'Shaughnessy,et al. Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone , 1983, Neuropharmacology.
[34] M. Åsberg,et al. "Serotonin depression"--a biochemical subgroup within the affective disorders? , 2003, Science.
[35] J. Weiss,et al. Effects of Acute Exposure to Stressors on Subsequent Avoidance‐Escape Behavior* , 1975, Psychosomatic medicine.
[36] N. Hirschhorn. Letter: Single solution for oral therapy of diarrhoea. , 1975, Lancet.
[37] B. Jacobs,et al. Brain stem and spinal cord mediation of a serotonergic behavioral syndrome , 1975, Brain Research.
[38] F. G. Henke,et al. Mental diagnosis by the association reaction method , 1909 .
[39] R. S. Sloviter,et al. Specificity of a rat behavioral model for serotonin receptor activation. , 1978, The Journal of pharmacology and experimental therapeutics.
[40] J. Bartlett,et al. SUBSTANCES RELATED TO 5‐HYDROXYTRYPTAMINE IN PLASMA AND IN LUMBAR AND VENTRICULAR FLUIDS OF PSYCHIATRIC PATIENTS , 1980, Acta psychiatrica Scandinavica.
[41] D. Middlemiss,et al. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. , 1983, European journal of pharmacology.
[42] M. H. Joseph,et al. Does in vivo voltammetry in the hippocampus measure 5-HT release? , 1982, Brain Research.
[43] A. Herbet,et al. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. , 1978, Molecular pharmacology.
[44] J. Axelrod. Studies on sympathomimetic amines. II. The biotransformation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine and d-methamphetamine. , 1954, The Journal of pharmacology and experimental therapeutics.
[45] W. Weiner,et al. Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration. , 1982, European journal of pharmacology.
[46] J. R. Hodges,et al. The effect of injected corticosterone on the release of adrenocorticotrophic hormone in rats exposed to acute stress , 1963, The Journal of physiology.
[47] S. Antelman,et al. Interchangeability of stress and amphetamine in sensitization. , 1980, Science.
[48] C. Pycock,et al. ‘Wet-Dog’ shake behaviour in the rat: A possible quantitative model of central 5-hydroxytryptamine activity , 1977, Neuropharmacology.
[49] H. Yamamura,et al. Discrimination of Multiple [3H]5‐Hydroxytryptamine Binding Sites by the Neuroleptic Spiperone in Rat Brain , 1981, Journal of neurochemistry.
[50] E. Paykel,et al. Contribution of life events to causation of psychiatric illness , 1978, Psychological Medicine.
[51] J. E. Platt,et al. Brain Adrenergic receptors and resistance to stress , 1982, Brain Research.
[52] G. Curzon,et al. Behavioural responses to drugs releasing 5-hydroxytryptamine and catecholamines: Effects of treatments altering precursor concentrations in brain , 1981, Neuropharmacology.
[53] M. H. Joseph,et al. The functional importance of increased brain tryptophan in the serotonergic response to restraint stress , 1981, Neuropharmacology.
[54] S. Nomura,et al. Stress and β-adrenergic receptor binding in the rat's brain , 1981, Brain Research.
[55] J. B. Stanton,et al. 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. , 1966, Lancet.
[56] C. Marsden,et al. The role of tryptamine in the behavioural effects of tranylcypromine + l-tryptophan , 1979, Neuropharmacology.